Related Experiment Videos

Ischemic heart disease, serum cholesterol, and apolipoproteins in CAPD

M H Gault1, L Longerich, V Prabhakaran

  • 1Faculty of Medicine, Memorial University of Newfoundland, St. John's, Canada.

ASAIO Transactions
|July 1, 1991
PubMed

Insights

Chronic ambulatory peritoneal dialysis (CAPD) patients exhibit elevated lipids and increased risk of ischemic heart disease. Apolipoprotein B (Apo-B) independently predicts heart disease severity in these patients.

Area of Science:

  • Nephrology
  • Cardiology
  • Clinical Chemistry

Background:

  • Chronic ambulatory peritoneal dialysis (CAPD) is a treatment for kidney failure.
  • Patients on CAPD often experience dyslipidemia, a risk factor for cardiovascular disease.
  • The relationship between CAPD-induced lipid changes and ischemic heart disease (IHD) requires further investigation.

Purpose of the Study:

  • To investigate the prevalence and severity of ischemic heart disease (IHD) in patients undergoing chronic ambulatory peritoneal dialysis (CAPD).
  • To determine the correlation between specific lipid parameters and the severity of IHD in CAPD patients.
  • To identify independent predictors of IHD in this patient population.

Main Methods:

  • Retrospective analysis of 31 CAPD patients (mean age 54 years, average CAPD duration 38 months).
  • Assessment of lipid profiles including triglycerides, total cholesterol (total-C), LDL-C, HDL-C, and Apolipoprotein B (Apo-B).
  • Grading of IHD severity based on patient history, electrocardiogram (EKG), echocardiography, and coronary angiography in a subset of patients.

Main Results:

  • Elevated triglycerides, total-C, LDL-C, and Apo-B, with low HDL-C were observed in CAPD patients.
  • Apolipoprotein B (Apo-B) and total-C/HDL-C ratio showed significant correlation with IHD severity (p < 0.001).
  • Apo-B was identified as the sole independent predictor of heart disease (p = 0.001) via logistic regression.

Conclusions:

  • CAPD patients present with significant dyslipidemia and a considerable burden of ischemic heart disease.
  • Apolipoprotein B is a strong indicator of IHD severity and an independent predictor of heart disease in CAPD patients.
  • The specific contribution of CAPD-induced lipid alterations to the development of IHD remains to be established.

Related Concept Videos